Revive Therapeutics Ltd. (RVV.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 328.00 | 434.00 | 578.00 | 775.00 | 28.26 Thousand | 3201.00 |
| Gross Profit | -328.00 | -434.00 | -578.00 | -775.00 | -28.26 Thousand | -3201.00 |
| Operating Expenses | 3.28 Million | 5.52 Million | 17.83 Million | 18.59 Million | 3.68 Million | 1.31 Million |
| Selling, General and Administrative Expenses | 2.17 Million | 1.93 Million | 2.67 Million | 11.88 Million | 3.2 Million | 1.19 Million |
| Research and Development Expenses | 1.11 Million | 3.58 Million | 15.15 Million | 6.7 Million | 455.08 Thousand | 124.8 Thousand |
| Other Expenses | - | - | 578.00 | 775.00 | 28.26 Thousand | 3201.00 |
| Cost and Expenses | 3.28 Million | 5.52 Million | 17.83 Million | 18.59 Million | 3.68 Million | 1.31 Million |
| Operating Income | -3.28 Million | -5.41 Million | -17.71 Million | -18.49 Million | -4.84 Million | -1.31 Million |
| Interest Expense | 23.28 Thousand | 43.99 Thousand | 63.42 Thousand | 78.98 Thousand | 87.65 Thousand | 2542.00 |
| Income Tax Expense | -2.3 Million | 43.99 Thousand | 26.7 Thousand | 78.98 Thousand | -1.11 Million | 27.38 Thousand |
| Earnings before Tax | -5.61 Million | -6.32 Million | -17.8 Million | -20.11 Million | -5.38 Million | -1.34 Million |
| Net Income | -5.61 Million | -6.32 Million | -17.83 Million | -20.19 Million | -4.26 Million | -1.37 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.06 | -0.08 | -0.04 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.06 | -0.08 | -0.04 | -0.02 |
| Weighted Average Shares Outstanding | 380.48 Million | 339.37 Million | 319.76 Million | 267.49 Million | 106.87 Million | 63.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 380.48 Million | 339.37 Million | 319.76 Million | 267.49 Million | 106.87 Million | 63.96 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.59 Million | -5.52 Million | -17.73 Million | -18.57 Million | -5.26 Million | -1.31 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 82.00 | 82.00 | 82.00 | 82.00 | 434.00 | 109.00 |
| Gross Profit | -82.00 | -82.00 | -82.00 | -82.00 | -434.00 | -109.00 |
| Operating Expenses | 233.24 Thousand | 1.85 Million | 784.25 Thousand | 413.52 Thousand | 5.52 Million | 354.89 Thousand |
| Selling, General and Administrative Expenses | 161.49 Thousand | 1.38 Million | 351.03 Thousand | 252.66 Thousand | - | 235.57 Thousand |
| Research and Development Expenses | 71.75 Thousand | 471.96 Thousand | 433.22 Thousand | 133.38 Thousand | - | 119.32 Thousand |
| Other Expenses | - | 1503.00 | - | - | - | - |
| Cost and Expenses | 233.32 Thousand | 1.85 Million | 784.33 Thousand | 413.52 Thousand | 5.52 Million | 355 Thousand |
| Operating Income | -233.32 Thousand | -1.85 Million | -784.33 Thousand | -383.14 Thousand | -5.41 Million | -355 Thousand |
| Interest Expense | 3131.00 | 4233.00 | 5904.00 | 7481.00 | 43.99 Thousand | 8958.00 |
| Income Tax Expense | -2.34 Million | -2.00 | -2.00 | -41.5 Thousand | 43.99 Thousand | 1.00 |
| Earnings before Tax | -2.58 Million | -1.87 Million | -770.62 Thousand | -390.62 Thousand | -6.32 Million | -1.19 Million |
| Net Income | -2.58 Million | -1.87 Million | -770.62 Thousand | -390.62 Thousand | -6.32 Million | -1.19 Million |
| Earnings Per Share Basic | -0.01 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 418.56 Million | 388.4 Million | 357.82 Million | 357.64 Million | 339.37 Million | 357.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 418.56 Million | 388.4 Million | 357.82 Million | 357.64 Million | 339.37 Million | 357.64 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.58 Million | -1.85 Million | -784.25 Thousand | -383.06 Thousand | - | -354.89 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ASY
OCUL
NUAG
RCAR
3962
DUKB